Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 4/20 | 0.46 |
| ▸ | HTR2C | P28335 | 3/20 | 0.46 |
| ▸ | HTR7 | P34969 | 3/20 | 0.46 |
| ▸ | HTR6 | P50406 | 2/20 | 0.46 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7385271 | 1.00 | MAOA (0.53) | MAOAHTR2AHTR2CHTR7HTR6 | |
| SCHEMBL7383115 | 0.83 | HTR2A (0.49) | MAOAHTR2AHTR2CHTR7HTR6 | |
| SCHEMBL7377224 | 0.83 | SIGMAR1 (0.39) | HTR2A | |
| SCHEMBL7383109 | 0.83 | HTR2A (0.49) | MAOAHTR2AHTR2CHTR7HTR6 | |
| SCHEMBL7377219 | 0.83 | SIGMAR1 (0.39) | HTR2A | |
| SCHEMBL7383126 | 0.82 | SLC6A3 (0.53) | MAOAHTR2AHTR2CKCNH2 | |
| SCHEMBL7383124 | 0.82 | SLC6A3 (0.53) | MAOAHTR2AHTR2CKCNH2 | |
| SCHEMBL23381594 | 0.80 | MAOA (0.53) | MAOAHTR2AHTR2CHTR7HTR6 | |
| SCHEMBL7378674 | 0.79 | HRH3 (0.56) | — | |
| SCHEMBL7378669 | 0.79 | HRH3 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5409929-A | Treating psychosis, dyskinesia | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1995-04-25 | — | — | US | disclosed |
| EP-0626947-A1 | HYDROISOINDOLINES AND HYDROISOQUINOLINES AS PSYCHOTROPIC DRUGS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-12-07 | — | — | EP | disclosed |
| WO-1993016047-A1 | HYDROISOINDOLINES AND HYDROISOQUINOLINES AS PSYCHOTROPIC DRUGS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-08-19 | — | — | WO | disclosed |
| US-5216018-A | Antidyskinetic agents | DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-06-01 | — | — | US | disclosed |